Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Mini Reviews in Medicinal Chemistry|June 3, 2022
Structural Perspective of Benzophenones Targeting Tubulin as Anticancer AgentsPrerna Chourasia, Vivek Asati, Shivangi Agarwal, et al.
Journal of Biomolecular Structure & Dynamics|June 6, 2022
Structural aspects of triazole derivatives as HSP90 inhibitors for the treatment of cancer: in silico studiesShubham Dhiman, Moumita Saha, Amena Ali, et al.
Current Pharmaceutical Design|June 15, 2016
Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive StrategiesVivek Asati, Sanjay K Bharti, Debarshi Kar Mahapatra, et al.
Future Medicinal Chemistry|July 11, 2026
LSD1-based dual-target inhibitors as emerging anticancer agents: pharmacological perspectives and SAR explorationPitam Ghosh, Ryena Dhir, Dinki Sharma, et al.
In Silico Pharmacology|April 18, 2022
Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophreniaAkash Rathore, Vivek Asati, Mitali Mishra, et al.
Molecular Diversity|April 20, 2024
Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancerAnushka Sharma, Rahul Dubey, Vikas Asati, et al.
Mini Reviews in Medicinal Chemistry|May 7, 2025
Recent Developments in Triazole Derivatives as α-Glucoside Inhibitors for the Treatment of DiabetesPriya Devi, Subhadip Maity, Shankar Gupta, et al.
Archiv Der Pharmazie|May 6, 2026
Current Landscape of Indole Hybrids in the Design and Development of Anti-Alzheimer Agents: Structural Insights, Therapeutic Potential and In Silico StudiesAkshad D Bagul, Mohd Irfan, Aashish Jaitak, et al.
Expert Opinion on Therapeutic Patents|August 12, 2025
An updated patent review on rational combinations of HDAC inhibitors for cancer chemotherapy (2020 - present): part 1-patent grantedYugal Kishor Shukla, Vandana, Vivekananda Mandal, et al.
Future Medicinal Chemistry|April 16, 2026
Novel pyrimidine-triazole conjugates for targeted inhibition of EGFR: synthesis and biological evaluationSubhadip Maity, Priya Devi, Aastha Singh, et al.
Pageof 7